Harvard's Allston development director steps down

Christopher M. Gordon, who came to the University when campus expansion was on the fast track, leaves in an era of readjusted expectations.

Christopher M. Gordon, who joined the University in 2005 to direct accelerated development of the University’s planned campus growth in Allston, has decided to relinquish his position. President Drew Faust announced in an e-mail today that Gordon, who is formally chief operating officer of the Allston Development Group (ADG), would be “stepping down from his position this summer.” Gordon’s departure suggests that Harvard development throughout Allston—already in a suspended state—is receding further into the future. He has focused professionally on the management of large, long-term planned projects (a broader role than overseeing construction projects per se)—the subject of his graduate work and teaching at MIT. In light of current circumstances, Gordon said in a statement, "The work I came here to do will be happening at a slower pace and intensity as announced by President Faust last December and that reality led to today’s announcement."

Construction of the first Allston project, a large scientific laboratory complex, has been halted, in line with the University’s announcement last winter. At the time, no date for resuming the work was projected, and Harvard raised the possibility of “co-development.” In light of the financial constraints imposed by the sharp decline in the value of the University’s endowment in late 2008 and early 2009, and the projected $1.4-billion cost of the science complex, it became clear that borrowing the sums required to proceed was not prudent. The scientists whose laboratories were to be sited in the new facility have been redirected to existing and renovated spaces in Cambridge and the Longwood Medical Area, making it possible that the partially built Allston complex will undergo changes of both design and ownership before it is finished. More broadly, the University has been seeking proposals for alternative uses, development options, and ownership structures for its Allston landholdings as a whole. But Harvard is not the only competitor in the market; Cambridge just approved a 1.7-million-square-foot biotechnology and research development in Kendall Square, which will be located closer to existing industry facilities and with faster access to the Massachusetts General Hospital complex than anything that might rise at the unfinished Allston science site.

The University announcement said that Gordon will continue to teach real-estate development at Harvard Business School (he also has been a lecturer at MIT, from which he earned his master’s in civil engineering), and advise on future capital projects. He and the ADG team have also been involved in planning and overseeing other major University capital programs: the reconstruction and expansion of the Fogg Art Museum, now under way; and initial planning for the renovation of undergraduate housing, a high priority for the Faculty of Arts and Sciences, but a potentially expensive ($1 billion or more) and long-term project.

Before coming to the University, Gordon was for a decade director of capital programs at the Massachusetts Port Authority, where he oversaw the $4.4-billion modernization of Logan Airport. 

You might also like

Roche to Be Tenant in Allston

First lease for Harvard’s commercial enterprise zone

Harvard Land Development Plans for Allston

Harvard presents its 10-year plan for institutional development in Allston.

Brief News Summary Harvard Spring 2025

President Garber’s private installation, settling antisemitism suits, challenging institutional neutrality, and more

Most popular

Shakespeare’s Greatest Rival

Without Christopher Marlowe, there might not have been a Bard.

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Five Questions with Peter R. Girguis

A Harvard professor of evolutionary biology on what lurks in the deep sea  

Explore More From Current Issue

Renaissance portrait of young man thought to be Christoper Marlowe with light beard, wearing ornate black coat with gold buttons and red patterns.

Shakespeare’s Greatest Rival

Without Christopher Marlowe, there might not have been a Bard.

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options. 

Colorful illustration of woman multitasking with laptop, baby bottle, toy, and checklist.

Motherhood and Ambition in a Pronatalist World

Gen Z is confronting the age-old question of balance—with a new twist.